Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma

Clinical trial NCT07495735 · RECRUITING

Trial details

NCT number: NCT07495735
Sponsor: First Affiliated Hospital of Wenzhou Medical University
Status: RECRUITING
Study type: OBSERVATIONAL

HCC - Hepatocellular Carcinoma Atezolizumab and Bevacizumab in Hepatocellular Carcinoma

Start date: 2026-03-22
Primary completion: 2026-12-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.